Charles River Laboratories International Inc
(NYSE:CRL)
$
214.2
25.52 (13.53%)
Market Cap: 10.95 Bil
Enterprise Value: 13.50 Bil
PE Ratio: 25.59
PB Ratio: 2.97
GF Score: 87/100 Charles River Laboratories International Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 14, 2022 / 02:00PM GMT
Release Date Price:
$202.32
(-5.22%)
Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst
Hey, everyone. Good morning. Thanks for joining us today. My name is Tejas Savant, and I'm the life science tools and diagnostics analyst at Morgan Stanley. It's my pleasure to host Charles River this morning. And with us, we have Jim Foster, CEO of Charles River.
Jim, before we kick it off, I just want to quickly rattle off the disclosures here. Please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. And if you have any questions, do reach out to your sales rep.
Questions & Answers
Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst
Jim, so thanks again for joining me.
James C. Foster
Charles River Laboratories International, Inc. - Chairman, CEO & President
Pleasure.
Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst
It's been sort of an unusual year for Charles River, puts and takes
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot